CD274 and neoplasm: As mentioned above, different chemotherapy drugs stimulate effective anti-tumor immune responses through different mechanisms, and cancer patients may reap more benefits with appropriate combination therapies after evaluating the tumor conditions, including PD-L1 expression level, immune cell infiltration, and tumor mutation burden.